# Effect of Telbivudine on Renal Function and Proteinuria in Patients With CHB & Chronic Renal Diseases

> **NCT02049736** · NA · WITHDRAWN · sponsor: **Chinese University of Hong Kong**

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** Telbivudine

## Key facts

- **NCT ID:** NCT02049736
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-12
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** unable to recruit patients
- **Last updated:** 2016-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02049736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02049736, "Effect of Telbivudine on Renal Function and Proteinuria in Patients With CHB & Chronic Renal Diseases". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02049736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*